ClinicalTrials.Veeva

Menu

Prehospital Recognition and Identification of Unspecific Symptoms (PRIUS)

Karolinska Institute logo

Karolinska Institute

Status

Completed

Conditions

Morality
Serious Condition

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

This study evaluates the predictive value of soluvent urokinase plasminogen activator receptor (suPAR) and lactate with respect to serious conditions among patients presenting to the EMS with unspecific symptoms.

Enrollment

414 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Unspecific symptoms (not feeling well, decreased general health condition, unable to cope with usual daily activities, feeling weak)
  • Normal vital signs
  • Transported to ED
  • Able to give informed consent/ Next of kin gives informed consent

Exclusion criteria

  • Specific symptoms
  • under 18 years of age
  • Stays home / other caregiver than ED
  • Referral from caregiver
  • No personal numer (social security number)

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems